Dermatitis News and Research RSS Feed - Dermatitis News and Research

Dermatitis is an infection of the skin. The skin may become itchy and progress to a bumpy red rash that may become tender. There may also be pus-filled blisters that are usually found surrounding hair follicles.
Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Researchers for the first time have identified the skin phenotype of pediatric eczema or atopic dermatitis (AD) in infants, opening the door for personalized treatment approaches for young children with eczema. [More]
Solution made of silver nanoparticles shows promise in healing diabetic foot ulcers

Solution made of silver nanoparticles shows promise in healing diabetic foot ulcers

One of the major complications of diabetes is the appearance of wounds in the lower extremities that do not heal properly. [More]
MRSA correlated to eczema? An interview with Dr Bjorn Herpers

MRSA correlated to eczema? An interview with Dr Bjorn Herpers

There is a lot of evidence that Staphylococcus aureus (S. aureus) is involved in eczema. Eczema is now thought to be caused by a barrier dysfunction of the skin that allows external triggers to cause an overshoot of inflammation. [More]
Cases of rotavirus infections fall by 84% thanks to vaccination

Cases of rotavirus infections fall by 84% thanks to vaccination

Figures published by Public Health England have shown that the number of diagnosed Rotavirus cases, a highly infectious virus which may cause vomiting and diarrhoea, have dropped by 84% since the introduction of a vaccine to the national childhood immunisation schedule in July 2013. [More]
Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Nearly 80 percent of peanut-allergic preschool children successfully incorporated peanut-containing foods into their diets after receiving peanut oral immunotherapy (OIT), a clinical trial has found. [More]

Researchers develop new approach to manufacturing mechanical metamaterials

Ill-fitting joint sockets, contact dermatitis and sebaceous cysts are just a few of the problems plaguing prosthetic patients. They are all a result of the pressure that their prosthetic devices place on the soft tissue of their bodies. [More]
Eczema can increase patients' risk of developing several other health conditions

Eczema can increase patients' risk of developing several other health conditions

When a patient is diagnosed with eczema, the diagnosis of another medical condition may not be far behind. [More]
Study finds link between eczema and S. aureus bacteria

Study finds link between eczema and S. aureus bacteria

A new study published in the British Journal of Dermatology has shown that, on average, 70% of eczema patients are colonised with Staphylococcus aureus bacteria (S. aureus, including MRSA) on their skin lesions. [More]
Ways to prevent, treat skin irritations after contact with poisonous plants

Ways to prevent, treat skin irritations after contact with poisonous plants

Poisonous plants cause the most common allergic reactions to the skin, affecting as many as 50 million Americans each year, according to the American Skin Association. University of Alabama at Birmingham associate professor of Emergency Medicine, Walter Schrading, M.D., says it is important people are able to identify poisonous plants, prevent an allergic reaction and treat skin irritations after contact. [More]
Laundry pods more likely to cause poisoning injuries in small children than nonpod detergents

Laundry pods more likely to cause poisoning injuries in small children than nonpod detergents

Laundry pod detergents are far more likely to cause poisoning injuries in young children than are nonpod laundry detergents, and are four times more likely to lead to hospitalization, according to findings published today from researchers at the University of Alabama at Birmingham. [More]
Early-life peanut consumption feasible and nutritionally safe for children, study finds

Early-life peanut consumption feasible and nutritionally safe for children, study finds

Introducing peanut-containing foods during infancy as a peanut allergy prevention strategy does not compromise the duration of breastfeeding or affect children's growth and nutritional intakes, new findings show. [More]
Subcutaneous treatment with cord blood stem cells improves eczema symptoms

Subcutaneous treatment with cord blood stem cells improves eczema symptoms

A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis. [More]
Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly. [More]
Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Elimination of the food that triggers atopic dermatitis, or eczema, is associated with increased risk of developing immediate reactions to that food, according to the results of a large-scale study recently published in the Journal of Allergy and Clinical Immunology. [More]
Domestic water hardness linked to eczema risk in children

Domestic water hardness linked to eczema risk in children

High levels of water hardness in the home may be linked to the development of eczema early in life, according to a new study led by King's College London. [More]
Study shows canine AD shares significant features of human version

Study shows canine AD shares significant features of human version

Atopic dermatitis (AD), a chronic inflammatory skin condition and the most common form of eczema, is estimated to afflict as much as 10 percent of the U.S. population, and is much more common now than it was 50 years ago. Veterinary clinical estimates also show that approximately 10 percent of dogs have atopic dermatitis. [More]
Researchers observe worrisome increase in anaphylaxis rate

Researchers observe worrisome increase in anaphylaxis rate

Anaphylaxis, known to be a sudden and potentially life-threatening allergic reaction, seems to be increasing among children, according to a new study led by a team at the Research Institute of the McGill University Health Centre. [More]
Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab was superior to adalimumab (marketed by AbbVie as HUMIRA) in improving signs and symptoms in patients with active rheumatoid arthritis (RA) at Week 24. [More]
Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME). [More]
Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that VIVLODEX (meloxicam) capsules, a nonsteroidal anti-inflammatory drug (NSAID), is now available by prescription at pharmacies across the United States. [More]
Advertisement
Advertisement